We are live on ! Find out more
RCAG

Rehmann Capital Advisory Group Portfolio holdings

AUM $1.92B
1-Year Est. Return 16.97%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+16.97%
3 Year Est. Return
+51.41%
5 Year Est. Return
+57.24%
10 Year Est. Return
AUM
$370M
AUM Growth
+$39.4M
Cap. Flow
+$34.4M
Cap. Flow %
9.29%
Top 10 Hldgs %
31.7%
Holding
354
New
49
Increased
168
Reduced
83
Closed
31

Sector Composition

Rank Sector Weight
1 Consumer Staples 9.88%
2 Financials 6.07%
3 Healthcare 4.57%
4 Materials 3.74%
5 Technology 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
151
Fifth Third Bancorp
FITB
$51.6B
$449K 0.12%
19,552
-661
-3% -$14.4K
HDV
152
iShares Core High Dividend ETF
HDV
$14.8B
$437K 0.12%
30,560
+4,185
+16% +$58K
SUB icon
153
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$428K 0.12%
4,031
+1
+0% +$106
PII icon
154
Polaris
PII
$4.02B
$424K 0.11%
3,037
+195
+7% +$26.3K
IJT icon
155
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.37B
$415K 0.11%
6,976
-720
-9% -$42.3K
SNY icon
156
Sanofi
SNY
$103B
$415K 0.11%
+7,945
New +$402K
ABBV icon
157
AbbVie
ABBV
$433B
$414K 0.11%
8,056
-310
-4% -$15.7K
KMB icon
158
Kimberly-Clark
KMB
$35.7B
$412K 0.11%
3,898
-14
-0.4% -$1.45K
UNH icon
159
UnitedHealth
UNH
$377B
$408K 0.11%
4,978
-515
-9% -$38.8K
SCHW
160
Charles Schwab
SCHW
$184B
$407K 0.11%
14,891
+4,164
+39% +$109K
BMY icon
161
Bristol-Myers Squibb
BMY
$134B
$405K 0.11%
7,800
-455
-6% -$24.2K
CAF
162
Morgan Stanley China A Share Fund
CAF
$317M
$397K 0.11%
18,416
+3,292
+22% +$73.3K
VNQ icon
163
Vanguard Real Estate ETF
VNQ
$39.3B
$394K 0.11%
5,578
+38
+0.7% +$2.6K
ALL icon
164
Allstate
ALL
$67.7B
$384K 0.1%
6,793
-372
-5% -$20K
GSK icon
165
GSK
GSK
$103B
$384K 0.1%
5,742
-115
-2% -$7.77K
BRK.A icon
166
Berkshire Hathaway Class A
BRK.A
$1.11T
$375K 0.1%
2
DES icon
167
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$375K 0.1%
16,500
NQU
168
DELISTED
NUVEEN QUALITY INCOME MUNI FD
NQU
$372K 0.1%
28,000
+1,665
+6% +$21.7K
BIIB icon
169
Biogen
BIIB
$29.8B
$362K 0.1%
1,185
+34
+3% +$10.8K
TEVA icon
170
Teva Pharmaceuticals
TEVA
$40.1B
$362K 0.1%
+6,857
New +$317K
AEP icon
171
American Electric Power
AEP
$69.9B
$356K 0.1%
7,019
+340
+5% +$16.5K
NEE icon
172
NextEra Energy
NEE
$181B
$356K 0.1%
14,872
-992
-6% -$22.5K
NVS icon
173
Novartis
NVS
$292B
$355K 0.1%
4,657
-2,124
-31% -$155K
PAA icon
174
Plains All American Pipeline
PAA
$17.1B
$354K 0.1%
6,419
+99
+2% +$5.2K
AGN
175
DELISTED
Allergan Inc
AGN
$353K 0.1%
2,845
+790
+38% +$96.2K

Similar funds

Rehmann Capital Advisory Group's Q1 2014 Portfolio in Review

As of Q1 2014, Rehmann Capital Advisory Group held 354 positions worth $370M, up 12% from $331M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rehmann Capital Advisory Group deployed $34.4M of net new capital in Q1 2014, opening 49 new positions and adding to 168 existing holdings. Its largest new stake was First Trust Dow Jones Internet Index Fund ETF: 9,000 shares worth $531K.

By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $429K trimmed.

  • Rehmann Capital Advisory Group's largest Q1 2014 buy was First Trust Dow Jones Internet Index Fund ETF: 9,000 shares worth $531K.
  • Rehmann Capital Advisory Group added most to Vanguard Morningstar Growth ETF in Q1 2014, an estimated $4.42M increase.
  • Rehmann Capital Advisory Group's biggest Q1 2014 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $429K.
  • Rehmann Capital Advisory Group fully exited iShares S&P Small-Cap 600 Value ETF in Q1 2014, selling an estimated $1.35M.
  • Rehmann Capital Advisory Group's ten largest holdings make up 32% of its $370M portfolio in Q1 2014.
  • Rehmann Capital Advisory Group opened 49 new positions and closed 31 in Q1 2014.
  • Rehmann Capital Advisory Group's portfolio value rose 12% quarter-over-quarter to $370M.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2014, filed 31 Aug 2015.